North American Scientific Inc (NASMQ1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
20200 SUNBURST ST CHATSWORTH, CA 91311

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

North American Scientific, Inc. designs, develops, produces and sells products for radiation therapy treatment, including Prospera brachytherapy seeds and SurTRAK needles and strands used primarily in the treatment of prostate cancer. The Company also develops and markets products for other medical, environmental, research and industrial applications. In September 2008, the Company sold its non-therapeutic product line to Eckert & Ziegler Isotope Products, Inc. In March 2009, the Company announced that it has filed voluntary petitions in United States Bankruptcy Court for the Central District of California for reorganization under Chapter 11 of the United States Bankruptcy Code.

View SEC Filings from NASMQ1 instead.

View recent insider trading info

Funds Holding NASMQ1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NASMQ1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROTH MICHAEL ANTHONY

STARK BRIAN JAY

  • 10% Owner
No longer subject to file 2009-04-17 0

RUSH JOHN BARRY PRESIDENT AND CEO

  • Officer
  • Director
1,000 2008-07-03 0

JAEGER WILFRED E

  • Director
  • 10% Owner
45,772,058 2008-04-30 0

YOUNG RODERICK A

  • Director
  • 10% Owner
45,772,058 2008-04-30 0

CUTRER L MICHAEL EXECUTIVE VP AND CTO

  • Officer
0 2008-04-29 0

TONI ROBERT V

  • Director
0 2008-04-29 0

SABIN JOHN

  • Director
0 2008-04-29 0

WILNER GARY N

  • Director
0 2008-04-29 0

SANDBERG RICHARD A

  • Director
0 2008-04-29 0

WYSENSKI NANCY

  • Director
No longer subject to file 2008-04-29 0

BARRING TROY A. SR. VICE PRESIDENT AND COO

  • Officer
0 2008-04-29 0

THREE ARCH MANAGEMENT IV, L.L.C.

THREE ARCH PARTNERS IV LP

THREE ARCH ASSOCIATES IV LP

TAC MANAGEMENT LLC

THREE ARCH CAPITAL LP

TAC ASSOCIATES LP

WAN MARK A

JAEGER WILFRED E

NICHOLSON BARCLAY

YOUNG RODERICK A

  • Director
  • 10% Owner
45,772,058 2008-01-18 0

CHL MEDICAL PARTNERS III LLC

CHL MEDICAL PARTNERS III SIDE FUND L P

CHL MEDICAL PARTNERS III L P

  • 10% Owner
12,195,120 2008-01-18 0

FRIEDE JOHN A

  • Director
  • 10% Owner
15,000 2007-06-05 0

THREE ARCH MANAGEMENT IV, L.L.C.

THREE ARCH PARTNERS IV LP

THREE ARCH ASSOCIATES IV LP

WAN MARK A

JAEGER WILFRED E

NICHOLSON BARCLAY

TAC MANAGEMENT LLC

THREE ARCH CAPITAL LP

TAC ASSOCIATES LP

  • 10% Owner
5,121,638 2006-06-06 0

KING DAVID NEIL VP & GENERAL COUNSEL

  • Officer
0 2006-05-03 0

KLINGLER JAMES W SR. VP AND CFO

  • Officer
65,000 2006-03-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments